Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017

September 6, 2024

Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…

Humm Group (ASX:HUM): Its no Big 4 Bank, but has defied the market in 2024

September 4, 2024

Humm Group (ASX:HUM) has not had the year you might expect to a financier that is not either a Big…

Percheron Therapeutics (ASX:PER): Releasing Phase II data by the end of CY24, and successful data could lead to a major re-rate

September 3, 2024

It has been less then a year since Antisense Therapeutics changed its name to Percheron Therapeutics (ASX:PER). It is common…

Qantas’ capex bill: The company is coping with a $12bn+ bullet for now, but will it eventually bite shareholders?

September 2, 2024

Qantas‘ capex needs are bubbling under the surface, but have not gone away. Former CEO Alan Joyce’s tenure came to…

Here are 5 key takeaways from the FY24 results of BHP that you may’ve missed

August 30, 2024

5 key takeaways from the FY24 results of BHP   1. Copper will be where ‘it is at’ from hereon…

Why do ASX REITs trade at a discount to NTA and is it a good or bad sign?

August 29, 2024

So, your ASX REIT is trading at a ‘discount to NTA’ (Net Tangible Assets). What does this mean – is…

Proteomics International Laboratories (ASX:PIQ): It thinks its got a great DKD detection test, but do regulators agree?

August 28, 2024

Proteomics International Laboratories (ASX:PIQ) is one of the larger companies that will be presenting at next month’s Life Sciences Conference.…

Here are 5 Monkeypox stocks to consider as the fight against the epidemic continues

August 26, 2024

Monkeypox stocks have enjoyed a good run in the last few weeks, with the World Health Organisation (WHO) classifying Monkeypox…

Here are 6 important milestones of ASX biotech companies other than clinical trial results and regulatory approval

August 23, 2024

The list of major milestones of ASX biotech companies is headed with clinical trial results, regulatory approval and commercialisation. However,…

Recce Pharmaceuticals investors are excited despite the market volatility – and there’s good reason

August 22, 2024

Recce Pharmaceuticals investors are amongst the few investors in ASX stocks that have a reason to smile right now. Their…

Retail Food Group (ASX:RFG): The most underrated ASX fast food stock might be about to boost its profile

August 22, 2024

Retail Food Group (ASX:RFG) is flying under many investors’ radars, and we think it is simply because its share price…

Here are 5 ASX stocks with fluctuating fortunes that have been firmly manifest this reporting season

August 21, 2024

Here are 5 ASX stocks with fluctuating fortunes (as observed this reporting season)   Baby Bunting (ASX:BBN) Baby Bunting has…

Auswide and MyState are merging, will the Big 4 Banks be watching closely?

August 19, 2024

The biggest market news on August 19, 2024 was that Auswide and MyState are merging. The two small cap bank…

Here are 4 economic indicators that impact stocks and investors must pay attention to

August 19, 2024

There are several economic indicators that impact stocks, both on the ASX and internationally. Whenever data is released, it can…

6 of the best performing ASX All Ords stocks in the past year

August 16, 2024

6 of the best performing ASX All Ords stocks in the past year   Clarity Pharmaceuticals (ASX:CU6) Clarity is a…